Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TCP1 alpha/CCTA anticorps (AA 3-106) (CF®647)

L’anticorps Souris Monoclonal anti-TCP1 alpha/CCTA a été validé pour WB, IF et FACS. Il convient pour détecter TCP1 alpha/CCTA dans des échantillons de Humain.
N° du produit ABIN6189924

Aperçu rapide pour TCP1 alpha/CCTA anticorps (AA 3-106) (CF®647) (ABIN6189924)

Antigène

Voir toutes TCP1 alpha/CCTA (TCP1) Anticorps
TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

Reactivité

  • 204
  • 135
  • 83
  • 21
  • 21
  • 20
  • 18
  • 17
  • 17
  • 15
  • 13
  • 11
  • 10
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 158
  • 48
  • 26
  • 1
  • 1
Souris

Clonalité

  • 138
  • 96
Monoclonal

Conjugué

  • 73
  • 16
  • 10
  • 8
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Cet anticorp TCP1 alpha/CCTA est conjugé à/à la CF®647

Application

  • 128
  • 71
  • 54
  • 53
  • 52
  • 43
  • 43
  • 41
  • 37
  • 24
  • 19
  • 12
  • 11
  • 2
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)

Clone

TP63-1786
  • Épitope

    • 39
    • 17
    • 17
    • 15
    • 15
    • 15
    • 15
    • 9
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 3-106

    Fonction

    Mouse Monoclonal anti-p63 (TP63/1786), CF647 Conjugate

    Attributs du produit

    p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands, however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90 % . Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80 %. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogène

    Recombinant human p63 protein fragment (aa3-106) (exact sequence is proprietary)

    Isotype

    IgG2b kappa
  • Indications d'application

    Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Immunofluorescence 1-2 μg/mL
    • Western blotting 0.5-1 μg/mL
    • Optimal dilution for a specific application should be determined by user

    Commentaires

    HEK293 cells or Prostate Carcinoma or Lung or bladder squamous cell carcinoma

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    100 μg/mL

    Buffer

    PBS/0.1 % BSA/0.05 % azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Protect from light
  • Antigène

    TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

    Autre désignation

    p63

    Poids moléculaire

    63 kDa

    ID gène

    8626, 137569

    UniProt

    Q9H3D4
Vous êtes ici:
Chat with us!